Home/Filings/4/0001493152-24-033900
4//SEC Filing

Hsu Jason 4

Accession 0001493152-24-033900

CIK 0001873835other

Filed

Aug 25, 8:00 PM ET

Accepted

Aug 26, 4:45 PM ET

Size

9.4 KB

Accession

0001493152-24-033900

Insider Transaction Report

Form 4
Period: 2024-08-21
Hsu Jason
Director
Transactions
  • Purchase

    Common Stock

    2024-08-22$2.25/sh+8,100$18,233845,300 total
  • Purchase

    Common Stock

    2024-08-21$2.23/sh+15,000$33,390837,200 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    50,000
  • Common Stock

    (indirect: See Footnote)
    3,915,913
Footnotes (4)
  • [F1]This transaction was executed in multiple trades at prices ranging from $2.22 to $2.23, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed in multiple trades at prices ranging from $2.162 to $2.29, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]Jason Hsu is the Sole Member of VERITAS LIBERABIT VOS, LLC and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Hsu disclaims beneficial ownership of the securities held by VERITAS LIBERABIT VOS, LLC, except to the extent of his pecuniary interest therein.
  • [F4]Jason Hsu is the Sole Member of Signature Collection Properties, LLC and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Hsu disclaims beneficial ownership of the securities held by Signature Collection Properties, LLC, except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

Immix Biopharma, Inc.

CIK 0001873835

Entity typeother

Related Parties

1
  • filerCIK 0001895035

Filing Metadata

Form type
4
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 4:45 PM ET
Size
9.4 KB